Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28350552 | 1.00 | PDE4A (0.67) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL29356160 | 1.00 | PDE4A (0.67) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL17144675 | 1.00 | PDE4A (0.67) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL6407 | 1.00 | PDE4A (0.67) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL10338405 | 0.98 | PDE4A (0.64) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL15121486 | 0.98 | PDE4A (0.64) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL15121487 | 0.98 | PDE4A (0.64) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL5077868 | 0.98 | PDE4A (0.64) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL725570 | 0.98 | PDE4A (0.64) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL20591201 | 0.98 | PDE4A (0.64) | PDE4ALMNAL3MBTL1TDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118576621-A | Application of fullerene nanomaterial targeting mannose receptor in preparation of medicine for treating liver steatosis | 中国科学院化学研究所 | 2024-09-03 | — | — | CN | claimed |
| CN-118579765-A | Fullerene nano material targeting mannose receptor and preparation method thereof | 中国科学院化学研究所 | 2024-09-03 | — | — | CN | claimed |
| CN-105820272-A | Perylene bisimide-cyclodextrin-sugar light dynamic compound and preparation method and application thereof | 河北大学 | 2016-08-03 | — | — | CN | claimed |
| CN-119950752-A | Protein nanoparticle with deformability and double targeting capability in response to pH, and preparation method and application thereof | 武汉大学 | 2025-05-09 | — | — | CN | disclosed |
| CN-118579765-A | Fullerene nano material targeting mannose receptor and preparation method thereof | 中国科学院化学研究所 | 2024-09-03 | — | — | CN | disclosed |
| CN-118576621-A | Application of fullerene nanomaterial targeting mannose receptor in preparation of medicine for treating liver steatosis | 中国科学院化学研究所 | 2024-09-03 | — | — | CN | disclosed |
| CN-105820272-A | Perylene bisimide-cyclodextrin-sugar light dynamic compound and preparation method and application thereof | 河北大学 | 2016-08-03 | — | — | CN | disclosed |
| WO-1999010359-A2 | LIPOSOMIC BASED SIALYL LEWIS X MIMETICS | NOVARTIS AG (CH) | 1999-03-04 | — | — | WO | disclosed |
| US-5837862-A | Sialyl Lewis X mimetics incorporating mannopeptides | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-11-17 | — | — | US | disclosed |